Dissecting Drug-Induced Cytotoxicity and Metabolic Dysfunction in Conditionally Immortalized Human Proximal Tubule...

Area of Science:

• Pharmacology
• Toxicology
• Cell Biology

Background:

• Drug-induced toxicity accounts for a significant portion of acute kidney injury cases.
• Pre-clinical assessment of renal toxicity is crucial for drug development.
• The MTT assay, commonly used for cell viability, relies on metabolic activity and may not accurately reflect toxicity when mitochondrial function is impaired.

Purpose of the Study:

• To highlight the limitations of the MTT assay in assessing renal toxicity of compounds that interfere with cellular metabolic activity.
• To compare the MTT assay with a plasma membrane permeability assay for evaluating nephrotoxic compounds.
• To propose a more comprehensive approach for pre-clinical renal toxicity assessment.

Main Methods:

• Exposure of proximal tubule epithelial cells to nephrotoxic compounds.
• Assessment of cellular metabolic activity using the MTT assay.
• Evaluation of plasma membrane permeability using a fluorescent assay.
• Comparison of results from both assays to determine compound cytotoxicity.

Main Results:

• Nephrotoxic compounds reduced cellular metabolic activity in a concentration- and time-dependent manner.
• The MTT assay provided a composite readout of cell death and metabolic impairment.
• The fluorescence-based plasma membrane permeability assay offered a distinct measure of cytotoxicity.
• MTT assay results differed from the plasma membrane permeability assay when mitochondrial function was affected.

Conclusions:

• The MTT assay alone is insufficient for assessing the cytotoxicity of compounds that induce metabolic dysfunction.
• An approach independent of cellular metabolism is preferable for evaluating such compounds.
• Combining MTT and plasma membrane permeability assays aids in distinguishing compounds with direct or indirect mitochondrial toxicity during drug development.